Association of T and NK Cell Phenotype with the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Rivas JL et al. (2018) Association of T and NK […]
Research Papers
Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment.
Roerink ME et al. (2017) Cytokine signatures in chronic fatigue
Pitfalls in cytokine measurements – Plasma TGF-β1 in chronic fatigue syndrome.
Pitfalls in cytokine measurements – Plasma TGF-β1 in chronic fatigue syndrome. Read More »
Roerink ME et al. (2018) Pitfalls in cytokine measurements –
The Common Immunogenic Etiology of Chronic Fatigue Syndrome: From Infections to Vaccines via Adjuvants to the ASIA Syndrome.
Rosenblum H et al. (2011) The Common Immunogenic Etiology of
Radiation exposure and mitochondrial insufficiency in Chronic Fatigue and Immune Dysfunction Syndrome
Rusin A et al. (2021) Radiation exposure and mitochondrial insufficiency
Illness progression in chronic fatigue syndrome: a shifting immune baseline.
Illness progression in chronic fatigue syndrome: a shifting immune baseline. Read More »
Russell L et al. (2016) Illness progression in chronic fatigue
Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome.
Russell A et al. (2018) Persistent fatigue induced by interferon-alpha:
Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity.
Ryabkova VA, et al . (2022) Autoantibody Correlation Signatures in
Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
Sasso EM et al . (2022) Transient receptor potential melastatin
Immunoadsorption to remove B2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.
Scheibenbogen C et al . (2018) Immunoadsorption to remove �2
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study.
Sc heibenbogen C et al. (2021) Tolerability and Efficacy of
Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome.
Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome. Read More »
Loebel M et al. (2014) Deficient EBV-Specific B- and T-Cell
Antibodies to ß adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.
Loebel M et al. (2016) Antibodies to � adrenergic and
Immunological aspects of chronic fatigue syndrome.
Immunological aspects of chronic fatigue syndrome. Read More »
Lorusso L et al. (2009) Immunological aspects of chronic fatigue
Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lutz L et al. (2021) Evaluation of Immune Dysregulation in
A systemic review and critical evaluation of the immunology of chronic fatigue syndrome.
A systemic review and critical evaluation of the immunology of chronic fatigue syndrome. Read More »
Lyall M et al. (2003) A systemic review and critical
Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations
Mandarano AH et al. (2019) Myalgic encephalomyelitis/chronic fatigue syndrome patients
Myalgic encephalomyelitis/ chronic fatigue syndrome as a breakdown of homeostasis.
Myalgic encephalomyelitis/ chronic fatigue syndrome as a breakdown of homeostasis. Read More »
Marks DF (2021) Myalgic encephalomyelitis/ chronic fatigue syndrome as a